Long-Term Follow-Up Outcomes of 7 Patients with HoFH Treated ≥9 Years in the Lomitapide LOWER Registry
Journal of Clinical Lipidology · 2026-06 · 20 (6) · e54
DOI: 10.1016/j.jacl.2026.05.082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2026-06. Verfasst von Dirk Blom und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Blom, D., Larrey, D., Makris, L., Ruddell, S., Aviezer, I., Louzado, R., Löwe, S., O'Brien, S., & Underberg, J. (2026). Long-Term Follow-Up Outcomes of 7 Patients with HoFH Treated ≥9 Years in the Lomitapide LOWER Registry. Journal of Clinical Lipidology, 20(6), e54. https://doi.org/10.1016/j.jacl.2026.05.082
Vancouver
Blom D, Larrey D, Makris L, Ruddell S, Aviezer I, Louzado R, et al. Long-Term Follow-Up Outcomes of 7 Patients with HoFH Treated ≥9 Years in the Lomitapide LOWER Registry. Journal of Clinical Lipidology. 2026;20(6):e54. doi:10.1016/j.jacl.2026.05.082
BibTeX
@article{Blom2026,
author = {Blom, Dirk and Larrey, Dominique and Makris, Lukas and Ruddell, Sam and Aviezer, Inbar and Louzado, Ruth and Löwe, Sandra and O'Brien, Sallyann and Underberg, James},
title = {Long-Term Follow-Up Outcomes of 7 Patients with HoFH Treated ≥9 Years in the Lomitapide LOWER Registry},
journal = {Journal of Clinical Lipidology},
year = {2026},
volume = {20},
number = {6},
pages = {e54},
doi = {10.1016/j.jacl.2026.05.082}
}
EUVIMED